1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About

AffaMed Therapeutics

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2019

Location

New York NY US

Primary Industry

Biotechnology

About

Based in the US and founded in 2019 and funded by the CBC Group, AffaMed Therapeutics is a biopharmaceutical company that addressing a critical unmet patient need in ophthalmic, neurological, and psychiatric disorders. AffaMed Therapeutics offers a platform to develop therapeutics and solutions to serve patients,
Current Investors
Partners Investment, CBC Group, Fountainhead Investment Partners

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biotechnology
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.